DVAX SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Dynavax...
January 09 2017 - 12:39PM
Business Wire
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Northern District of
California on behalf of investors who purchased Dynavax
Technologies Corporation (NASDAQ:DVAX) securities between March 10,
2014 and November 11, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/dynavax-technologies-corporation.
There is no cost or obligation to you.
According to the complaint, during the Class Period Dynavax made
false and/or misleading statements and/or failed to disclose that:
(i) the phase 3 HBV-23 trial for the Company’s lead vaccine product
HEPLISAV-B was not designed in accordance with the U.S. Food and
Drug Administration’s concerns and issues, as pointed out in a 2013
Complete Response Letter; (ii) Dynavax failed to provide sufficient
information to the FDA in its Revised Biologics License Application
for the drug; (iii) Dynavax’s resources will not be sufficient for
the Company to advance the HEPLISAV-B program on its own; and (iv)
as a result of the foregoing, the Company’s financial statements,
as well as Defendants’ statements about Dynavax’s business,
operations, and prospects, were false and misleading and/or lacked
a reasonable basis.
If you suffered a loss in Dynavax you have until January 17,
2017 to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Vincent
Wong, Esq. either via email vw@wongesq.com, by telephone at
212.425.1140, or visit
http://www.wongesq.com/pslra/dynavax-technologies-corporation.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
CONTACT:Vincent Wong, Esq.39 East BroadwaySuite 304New York, NY
10002Tel. 212.425.1140Fax. 866.699.3880E-Mail: vw@wongesq.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170109006120/en/
Law Offices of Vincent WongVincent Wong,
Esq.212.425.1140vw@wongesq.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2023 to Mar 2024